CCT4 and osteosarcoma: In osteosarcoma models, CCT4 was found to be indispensable for cancer cell survival: CRISPR/Cas9 knockout of CCT4 was lethal to osteosarcoma cells, and even partial knockdown significantly impaired their clonogenic growth and invasion (40).